Back to News
Infocepts Named a Seasoned Vendor in AIM Research’s 2026 PeMa Quadrant

McLean, VA, July 2026 – Infocepts has been named a Seasoned Vendor in AIM Research’s PeMa Quadrant for AI Service Providers in Life Sciences and Healthcare. This recognition highlights Infocepts’ ability to move AI from experimentation to production inside regulated, data-intensive, and document-heavy healthcare and life sciences environments.

The PeMa Quadrant evaluates AI service providers across two core dimensions: market penetration and delivery maturity. AIM Research assessed 14 AI service providers through RFIs, capability briefings, solution demonstrations, and case studies to understand which providers can deliver enterprise-ready AI at scale. Read more about the AIM Research 2026 PeMa Quadrant study.

Why This Recognition Matters

For life sciences and healthcare organizations, the AI conversation has moved beyond whether AI works. The bigger question now is which providers can deploy AI responsibly, govern it effectively, and keep it performing in environments where accuracy, explainability, auditability, and compliance are essential.

Infocepts’ recognition as a Seasoned Vendor reflects its focus on production-grade AI, governed data foundations, and decision intelligence capabilities that help organizations move from insights to embedded workflows.

  • 70% of Infocepts’ AI revenue in this vertical comes from repeat customers.
  • Clients are expanding from initial engagements into enterprise transformation programs.
  • AI solutions are being embedded into day-to-day commercial, medical, and operational workflows.
  • Governance, explainability, audit trails, and human-in-the-loop validation are built into the architecture from the start.

From AI Insights to Enterprise Workflows

Infocepts’ work in life sciences and healthcare is increasingly focused on helping organizations operationalize AI across commercial, medical, clinical, safety, and patient operations. The report noted Infocepts’ shift from insight generation to workflow enablement, with AI capabilities now supporting MSL enablement, HCP engagement, CRM intelligence, and next-best-action recommendations.

This aligns with the broader industry need for a connected intelligence layer, where AI does not sit only in dashboards but supports real business decisions across teams. Learn more about Infocepts’ approach to connected intelligence for pharma commercial teams.

Built on Governed AI and Decision Intelligence

Infocepts’ AI framework for life sciences and healthcare is built on solutions including Pharma360, Field Buddy, iSimplify, and AQuA, orchestrated through its Decision Intelligence approach for governed AI deployment.

This framework helps clients unify fragmented data, build semantic and governed data layers, and apply AI responsibly across regulated business functions. It is designed to support practical enterprise use cases such as commercial analytics, medical affairs intelligence, HCP engagement, field force effectiveness, clinical operations, and compliant AI adoption.

Explore Infocepts’ broader capabilities for life sciences and healthcare data analytics.

AI That Works Inside Regulated Environments

In regulated functions, AI must be designed with governance from the beginning. AIM Research noted that explainability, audit trails, human-in-the-loop validation, and alignment with standards such as GxP, HIPAA, GDPR, and 21 CFR Part 11 are becoming core parts of AI architecture rather than final-stage compliance checks.

Infocepts’ delivery model combines AI and data engineering expertise with deep life sciences domain knowledge. This helps organizations move beyond fixed-scope automation and reengineer the underlying processes required to make AI reliable, scalable, and business-ready.

An Ecosystem Built to Scale

Infocepts’ AI services are strengthened by partnerships across Databricks, Snowflake, Microsoft Azure, AWS, and Dataiku. These ecosystem relationships help clients modernize platforms, build governed data foundations, and accelerate AI deployment across enterprise environments.

For example, Infocepts has helped pharma organizations improve field sales operations through AI-powered insights, next-best-action intelligence, and real-time analytics. Read the related customer story on AI-powered field salesforce transformation for a global pharma leader.

The Next Chapter: Agentic AI for Life Sciences and Healthcare

The foundation is set for the next phase of AI in life sciences and healthcare. Infocepts is investing in modular Agentic AI capabilities to support emerging opportunities across clinical trials, manufacturing, R&D, regulatory operations, and enterprise decision workflows.

As organizations look to scale AI responsibly, Infocepts remains focused on helping them build production-ready systems that are governed, explainable, and aligned to measurable business outcomes.

Talk to Infocepts experts to learn how governed AI and decision intelligence can help your life sciences or healthcare organization move from AI pilots to enterprise-scale transformation.